Jackson Creek Investment Advisors LLC Tarsus Pharmaceuticals, Inc. Transaction History
Jackson Creek Investment Advisors LLC
- $274 Million
- Q2 2024
A detailed history of Jackson Creek Investment Advisors LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 29,524 shares of TARS stock, worth $978,720. This represents 0.29% of its overall portfolio holdings.
Number of Shares
29,524
Previous 29,577
0.18%
Holding current value
$978,720
Previous $1.08 Million
25.4%
% of portfolio
0.29%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
155Shares Held
40.4MCall Options Held
37.9KPut Options Held
808K-
Rtw Investments, LP New York, NY3.41MShares$113 Million1.55% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$108 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$80.7 Million2.68% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$74.7 Million7.48% of portfolio
-
Cowen And Company, LLC2.2MShares$72.8 Million1.53% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $884M
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...